Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1976 2
1977 3
1978 2
1980 2
1981 2
1982 4
1983 1
1984 3
1986 2
1987 2
1988 2
1989 3
1990 2
1991 1
1992 4
1993 1
1994 2
1995 2
1996 2
1997 2
1998 3
2000 1
2001 2
2002 6
2003 6
2004 6
2005 7
2006 6
2007 8
2008 12
2009 12
2010 13
2011 10
2012 11
2013 22
2014 16
2015 23
2016 19
2017 22
2018 14
2019 7
2020 3
2021 7
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

251 results
Results by year
Filters applied: . Clear all
Page 1
The carbon tetrachloride model in mice.
Scholten D, Trebicka J, Liedtke C, Weiskirchen R. Scholten D, et al. Among authors: liedtke c. Lab Anim. 2015 Apr;49(1 Suppl):4-11. doi: 10.1177/0023677215571192. Lab Anim. 2015. PMID: 25835733
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.
Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G, Lebeau A, Liedtke C, von Minckwitz G, Nekljudova V, Schmatloch S, Schrenk P, Staebler A, Untch M. Kuehn T, et al. Among authors: liedtke c. Lancet Oncol. 2013 Jun;14(7):609-18. doi: 10.1016/S1470-2045(13)70166-9. Epub 2013 May 15. Lancet Oncol. 2013. PMID: 23683750
Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis.
Liao L, Schneider KM, Galvez EJC, Frissen M, Marschall HU, Su H, Hatting M, Wahlström A, Haybaeck J, Puchas P, Mohs A, Peng J, Bergheim I, Nier A, Hennings J, Reißing J, Zimmermann HW, Longerich T, Strowig T, Liedtke C, Cubero FJ, Trautwein C. Liao L, et al. Among authors: liedtke c. Gut. 2019 Aug;68(8):1477-1492. doi: 10.1136/gutjnl-2018-316670. Epub 2019 Mar 14. Gut. 2019. PMID: 30872395
Mast Cells in Liver Fibrogenesis.
Weiskirchen R, Meurer SK, Liedtke C, Huber M. Weiskirchen R, et al. Among authors: liedtke c. Cells. 2019 Nov 13;8(11):1429. doi: 10.3390/cells8111429. Cells. 2019. PMID: 31766207 Free PMC article. Review.
West German Study PlanB Trial: Adjuvant Four Cycles of Epirubicin and Cyclophosphamide Plus Docetaxel Versus Six Cycles of Docetaxel and Cyclophosphamide in HER2-Negative Early Breast Cancer.
Nitz U, Gluz O, Clemens M, Malter W, Reimer T, Nuding B, Aktas B, Stefek A, Pollmanns A, Lorenz-Salehi F, Uleer C, Krabisch P, Kuemmel S, Liedtke C, Shak S, Wuerstlein R, Christgen M, Kates RE, Kreipe HH, Harbeck N; West German Study Group PlanB Investigators. Nitz U, et al. Among authors: liedtke c. J Clin Oncol. 2019 Apr 1;37(10):799-808. doi: 10.1200/JCO.18.00028. Epub 2019 Feb 20. J Clin Oncol. 2019. PMID: 30785826 Clinical Trial.
De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12 weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel.
Nitz UA, Gluz O, Christgen M, Grischke EM, Augustin D, Kuemmel S, Braun M, Potenberg J, Kohls A, Krauss K, Stefek A, Schumacher C, Forstbauer H, Reimer T, Fischer H, Liedtke C, Wuerstlein R, Schumacher J, Kates R, Kreipe H, Harbeck N. Nitz UA, et al. Among authors: liedtke c. Ann Oncol. 2017 Nov 1;28(11):2768-2772. doi: 10.1093/annonc/mdx494. Ann Oncol. 2017. PMID: 28945833 Free article. Clinical Trial.
Targeting Wnt Signaling via Notch in Intestinal Carcinogenesis.
Kaemmerer E, Jeon MK, Berndt A, Liedtke C, Gassler N. Kaemmerer E, et al. Among authors: liedtke c. Cancers (Basel). 2019 Apr 18;11(4):555. doi: 10.3390/cancers11040555. Cancers (Basel). 2019. PMID: 31003440 Free PMC article. Review.
251 results